The face of cosmetic procedures is changing along with non-invasive procedures adding to the aesthetics toolbox offered by plastic surgery. Nowadays, injectable treatments approach millions of procedures annually. The overpowering success of botulinum toxin and dermal fillers in curing wrinkles is well-known, however, these kinds of injectable aren’t the only one making waves. Perhaps the foremost reason behind the growing popularity of non-surgical cosmetic procedures is allowing manufacturers to create an anti-aging regimen that works proactively. In recent times, people don’t have to wait for the natural aging process to justify the recovery time and expenses associated with many plastic surgeries. Therefore, dermal fillers in the healthcare industry are gaining significant importance, as they offer a range of preventive care that can help in maintaining smooth and wrinkle-free skin. Consumers, particularly women today, take a keen interest in maintaining their skin. Some are willing to spend on high-priced skincare products and others treat their skin with regular facials, while a majority of them approach doctors for treatments.
FDA Approved One-of-a-Kind Dermal Filler
Over decades, injectables and fillers have been heralded as the remedy for adding youthful-looking lost volume back to the face, thereby improving facial features and filling wrinkles and lines. Currently, fillers are enhancing not only lips and cheeks but also the back of the hands. In 2019, the Food and Drug Administration (FDA) approved Restylane Lyft that can be used on the back of the hands. It is the only hyaluronic acid (HA) dermal filler that has received approval for an area other than the face. More durable options are also on the horizon – currently in development are fillers that use HA combined with silk-derived proteins and small blunt tip cannula for the improvement based on age-related contour deficiencies of the nose and cheek augmentation of patients over 21 years age. Alongside, FDA has also granted approval to a few more HA dermal fillers such as Teosyal, Teosyal RHA, and Revanesse Versa. These fillers are widely used for the most mobile area of the face and can plump certain parts of the face.
With a wealth of new products in the marketplace, manufacturers such as Galderma and Nestle Skin Health have increased their investment in R&D activities, in order to strengthen their position in the facial aesthetic market. The latter company focuses on offering new solutions and delivery systems to the customers to build a strong foothold in the dermal filler market.
Development of Juvederm Volite to Take Marketing Campaigns to New Highs
In line with increasing consumers’ quest for value-added care, Juvederm Volite, an innovative injectable, emerged as a game-changer treatment in the market. It is an anti-aging and injectable anti-wrinkle treatment, developed to enhance the quality of the skin from inside out for 9 months with just one treatment session. Volite is injected in the middle layers of the dermis and immediately plumps and hydrates the skin. This treatment is becoming increasingly popular across the globe. In January 2020, Juvederm Volite was launched in India and showcasing a positive result.
Other leading companies in the market are strategizing to reach out to the millennials through advertising campaigns. In February 2020, Allergan started an advertising campaign for the company’s Juvederm dermal filler as its counterintuitive strategy. Allergan has specifically addressed millennials’ preference for using cosmetic fillers, either before or without injecting Botox. The company is also working towards its merger with AbbVie. This merger is not expected to affect the future of its aesthetic products and the revenue from these products will continue to witness healthy growth.
Liquid Rhinoplasty: The Safest Way to Reshape Nose?
With the emergence of non-invasive treatments across the cosmetic range, liquid rhinoplasty is making an appearance as the most suitable non-surgical alternative to traditional plastic and reconstructive surgery of the nose. In order to change the appearance of the nose using dermal fillers, non-surgical rhinoplasty is gaining momentum, as it is a convenient, cost-effective, and early recovery solution. Previously, there have been debates regarding the side effects of this procedure. Moreover, the American Society of Plastic Surgeons (ASPS) issued an analysis of 5,000 non-surgical rhinoplasties that were conducted during 2015-2019, becoming the largest published experience of non-surgical rhinoplasty to date. The study outlines an effective and safe alternative to the surgical rhinoplasty technique focusing on three critical aesthetic points of the nose – the bridge, the radix, and the tip. These benefits of liquid rhinoplasty are attracting a large number of millennials who want to get their nose job done without going through reconstructive and plastic surgery.
Dermal fillers treatment is a rapidly growing method of facial rejuvenation. Showing instant results with a minimally invasive procedure, dermal filler agents such as hyaluronic acid fillers are injected for cosmetic volume improvements. Such improvement along with faster approval from the FDA for new dermal fillers is highly responsible for concentrated competition among the market players.
Several companies are focusing on product innovations for dermal fillers to stay ahead of the curve. For instance, in 2019, Merz Pharma launched Belotero Revive, a dermal filler along with hyaluronic acid and glycerol esters. In addition, Allergan Pharma launched VOLUX, a dermal filler for the refinement of chin and jawline. These captivating strategies are influencing the local and regional players to bring significant innovations in their product development.